Trials Annotator

Org. Study IDs: NO-SARS-COVID-19

Last trial update was posted on 2023-02-08

Nitric Oxide

COVID-19 Severe Acute Respiratory Syndrome Syndrome

Coronavirus Covid-19 Infection Variant Omicron SARS (Severe Acute Respiratory Syndrome)

The study will start to enroll patients soon

N/A

Al Sulaiman K, Korayem GB, Altebainawi AF, Al Harbi S, Alissa A, Alharthi A, Kensara R, Alfahed A, Vishwakarma R, Al Haji H, Almohaimid N, Al Zumai O, Alrubayan F, Asiri A, Alkahtani N, Alolayan A, Alsohimi S, Melibari N, Almagthali A, Aljahdali S, Alenazi AA, Alsaeedi AS, Al Ghamdi G, Al Faris O, Alqahtani J, Al Qahtani J, Alshammari KA, Alshammari KI, Aljuhani O. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study. Crit Care. 2022 Oct 3;26(1):304. doi: 10.1186/s13054-022-04158-y. [PMID: 36192801] [DOI: 10.1186/s13054-022-04158-y]

No annotators decided on categories yet

#	Outdated	Intervention				Condition
#	Outdated	Name		Route	DrugBank ID	Condition